Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Human cord blood long-term engrafting cells are CD34+ CD38

Abstract

There have been controversies about CD34 and CD38 expression by human cord blood (CB) stem cells. Using the newborn NOD/SCID/β2-microglobulin-null mouse assay that we recently developed, we examined the in vivo engrafting capability of human CB cells. Almost all of the 4–5 months engrafting cells were found in CD34+ population. The capability of secondary reconstitution was found only in the CD34+ cells. When the CD34+ CB cells were separated into CD38 and CD38+ subpopulations and tested for engraftment, the majority of the engrafting cells were detected in the CD38 subpopulation. These findings are consistent with the results from studies of murine stem cells and strongly indicate that the phenotype of human CB stem cells is CD34+ CD38.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Osawa M, Hanada K, Hamada H, Nakauchi H . Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242–245.

    Article  CAS  Google Scholar 

  2. Sato T, Laver JH, Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells. Blood 1999; 94: 2548–2554.

    CAS  Google Scholar 

  3. Ito T, Tajima F, Ogawa M . Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp Hematol 1999; 28: 1269–1273.

    Article  Google Scholar 

  4. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick J . A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038–1045.

    Article  CAS  Google Scholar 

  5. Nakamura Y, Ando K, Chargui J, Kawada H, Sato T, Tsuji T et al. Ex vivo generation of CD34+ cells from CD34 hematopoietic cells. Blood 1999; 94: 4053–4059.

    CAS  Google Scholar 

  6. Ando K, Nakamura Y, Chargui J, Matsuzawa H, Tsuji T, Kato S et al. Extensive generation of human cord blood CD34+ stem cells from Lin CD34 cells in a long-term in vitro system. Exp Hematol 2000; 28: 690–699.

    Article  CAS  Google Scholar 

  7. Verstegen MMA, van Hennik PB, Terpstra W, van den Bos C, Wielenga JJ, van Rooijen N et al. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38− cells. Blood 1998; 91: 1966–1976.

    CAS  PubMed  Google Scholar 

  8. Gao Z, Fackler MJ, Leung W, Lumkul R, Ramirez M, Theobald N et al. Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34 cell preparations. Exp Hematol 2001; 29: 910–921.

    Article  CAS  Google Scholar 

  9. Ishikawa F, Livingston AG, Wingard J, Nishikawa S-I, Ogawa M . An assay for long-term engrafting human cells based on NOD/SCID/β2-microglobulin null mice. Exp Hematol 2002; 30: 488–494.

    Article  CAS  Google Scholar 

  10. Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L, et al. β2 Microglobulin-deficient (B2mnull)NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000; 95: 3102–3105.

    CAS  PubMed  Google Scholar 

  11. Glimm H, Eisterer W, Lee K, Cashman J, Holyoke TL, Nicolini F et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobuin-null mice. J Clin Invest 2001; 107: 199–206.

    Article  CAS  Google Scholar 

  12. Ogawa M . Changing phenotypes of hematopoietic stem cell. Exp Hematol 2002; 30: 3–6.

    Article  Google Scholar 

  13. Tajima F, Sato T, Laver JH, Ogawa M . CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood 2000; 96: 1989–1993.

    CAS  PubMed  Google Scholar 

  14. Tajima F, Deguchi T, Laver JH, Zeng H, Ogawa M . Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. Blood 2001; 97: 2618–2624.

    Article  CAS  Google Scholar 

  15. Dagher RN, Hiatt K, Traycoff C, Srour EF, Yoder M . c-Kit and CD38 are expressed by long-term reconstituting hematopoietic cells present in murine yolk sac. Biol Blood Marrow Transplant 1998; 4: 69–74.

    Article  CAS  Google Scholar 

  16. Randall TD, Lund FE, Howard MC, Weissman IL . Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 1996; 87: 4057–4067.

    CAS  PubMed  Google Scholar 

  17. Higuchi Y, Zeng H, Ogawa M . CD38 expression by hematopoietic stem cells of newborn and juvenile mice. Leukemia 2003; 17: 171–174.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Krista E Harris and Deidre R Wright for the excellent care of immunocompromised mice.

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by the Office of Research and Development, Medical Research Services, Department of Veterans Affairs and by the Grants PO1-CA78582 and RO1-DK54197 from the National Institutes of Health

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishikawa, F., Livingston, A., Minamiguchi, H. et al. Human cord blood long-term engrafting cells are CD34+ CD38. Leukemia 17, 960–964 (2003). https://doi.org/10.1038/sj.leu.2402878

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402878

Keywords

This article is cited by

Search

Quick links